查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573854

体外受精（IVF）市场、机会、成长动力、产业趋势分析与预测，2024-2032

In-vitro Fertilization (IVF) Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 250 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球体外受精市场估值为 202 亿美元，预计 2024 年至 2032 年复合年增长率为 5.7%，主要由不孕率上升推动。根据世界卫生组织 (WHO) 报告，全球约有 1.86 亿人患有不孕症。此外，多囊性卵巢症候群（PCOS）和子宫内膜异位症等疾病影响全球十分之一的女性，这也加剧了对体外受精的需求。

体外受精是一种透过在人体体外的实验室环境中使卵子受精，然后将胚胎移植到女性子宫中来帮助受孕的医疗程序。作为辅助生殖技术 (ART) 的一种流行且有效的形式，体外受精可解决各种不孕症挑战，包括排卵障碍、输卵管受损和男性不孕症。

不孕不育病例的激增极大地推动了市场。例如，世界卫生组织的资料显示，全球有六分之一的人面临不孕症，凸显了对生育照护的迫切需求。技术进步显着提高了体外受精的成功率。例如，IVF 的成功率已从 1980 年代的约 10% 飙升至 2023 年每个週期的约 30-35%，具体取决于女性的年龄。延时成像技术使胚胎学家能够密切监测胚胎髮育，提高选择和植入成功率，从而提高体外受精的整体成功率。

整个产业分为产品、週期类型、程序、最终用途和地区。

按产品细分的市场包括设备、试剂和介质以及配件。设备领域到2023 年将引领市场，估值将达94 亿美元，涵盖多种领域，包括显微镜、成像系统、精子分析仪、卵子抽吸泵、显微操作器、培养箱、气体分析仪、低温系统、雷射系统、精子分离系统、机柜、防震台、见证系统和其他专用设备。

按週期类型细分显示新鲜非捐赠者、冷冻非捐赠者、冷冻捐赠者和新鲜捐赠者。新的非捐赠者由于其卓越的成功率，在 2023 年占据了 48.1% 的份额。在取出卵子后立即使用女性自己的卵子，新鲜的非捐赠週期有更高的成功率。这项优势源自于卵子不会因冷冻和解冻而改变，而冷冻和解冻过程可能会损害其品质。

北美引领全球体外受精市场，2023 年收入为 62 亿美元，预计到 2032 年将飙升至 98 亿美元。及且有效的。延迟生育、生活方式选择和健康状况等因素导致了该地区的生育挑战。由于许多夫妇因职业或个人原因而推迟生育，对生育治疗（尤其是体外受精）的需求激增。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 不孕率上升
      • 技术进步和生育产业的扩张
      • 怀孕中位年龄增加
      • 有利的政府倡议
    • 产业陷阱与挑战
      • 与生育手术相关的高成本
      • 社会和道德问题，尤其是发展中国家的社会和道德问题
  • 成长潜力分析
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 装置
    • 显微镜
    • 影像系统
    • 精子分析仪系统
    • 抽卵泵
    • 显微作业系统
    • 孵化器
    • 气体分析仪
    • 冷冻系统
    • 雷射系统
    • 精子分离系统
    • 内阁
    • 防震台
    • 见证系统
    • 其他设备
  • 试剂和介质
    • 胚胎培养基
    • 冷冻保存介质
    • 精子处理介质
    • 卵子处理培养基
  • 配件

第 6 章：市场估计与预测：按週期类型，2021 年至 2032 年

  • 主要趋势
  • 新的非捐赠者
  • 冻结非捐赠者
  • 冷冻捐赠者
  • 新的捐赠者

第 7 章：市场估计与预测：按程序，2021 - 2032

  • 主要趋势
  • 传统体外受精
  • IVF 胞浆内单一精子注射
  • 最小体外受精
  • 使用捐赠卵子进行体外受精
  • 其他手续

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 生育诊所和试管受精中心
  • 医院和外科中心
  • 科学研究机构
  • 冷冻库

第 9 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • Cook Medical
  • Esco Medical
  • FUJIFILM Irvine Scientific, Inc.
  • GE HealthCare Technologies, Inc.
  • Genea BIOMEDX
  • Gynemed GmbH and Co. KG
  • Hamilton Thorne Ltd.
  • IVFtech ApS
  • Kitazato Corporation
  • Merck KGaA
  • Nidacon International AB
  • The Baker Company Inc.
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific Inc.
  • Vitrolife Group
简介目录
Product Code: 11083

The Global In-Vitro Fertilization Market was valued at USD 20.2 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2032, primarily driven by rising infertility rates. As reported by the World Health Organization (WHO), approximately 186 million individuals globally grapple with infertility. Furthermore, conditions like polycystic ovary syndrome (PCOS) and endometriosis, impacting 1 in 10 women worldwide, are fueling the heightened demand for IVF.

In-vitro fertilization is a medical procedure that aids conception by fertilizing an egg in a lab setting outside the human body and subsequently transferring the embryo into the woman's uterus. As a prevalent and effective form of Assisted Reproductive Technology (ART), IVF addresses various infertility challenges, including ovulation disorders, damaged fallopian tubes, and male infertility.

The surging infertility cases significantly propel the market. For instance, WHO data reveals that 1 in 6 individuals globally faces infertility, underscoring the pressing need for fertility care. Technological strides have markedly bolstered IVF success rates. For instance, IVF success rates have surged from roughly 10% in the 1980s to about 30-35% per cycle in 2023, contingent on the woman's age. Time-lapse imaging technology empowers embryologists to closely monitor embryo development, enhancing selection and implantation success rates, and thereby boosting overall IVF success.

The overall industry is classified into product, type of cycle, procedure, end-use, and region.

Market segmentation by product includes equipment, reagents and media, and accessories. The equipment segment, leading the market in 2023 with a valuation of USD 9.4 billion, encompasses a diverse range including microscopes, imaging systems, sperm analyzers, ovum aspiration pumps, micromanipulators, incubators, gas analyzers, cryosystems, laser systems, sperm separation systems, cabinets, anti-vibration tables, witness systems, and other specialized equipment.

Segmentation by cycle type reveals fresh non-donors, frozen non-donors, frozen donors, and fresh donors. The fresh non-donors led with a 48.1% share in 2023, attributed to their superior success rates. Utilizing a woman's own eggs immediately post-retrieval, fresh non-donor cycles boast higher success rates. This advantage stems from the eggs being unaltered by freezing and thawing, processes that could compromise their quality.

North America led the global in-vitro fertilization market with revenue of USD 6.2 billion in 2023, projected to soar to USD 9.8 billion by 2032. Renowned for its cutting-edge medical technology, North American fertility clinics leverage latest advancements in reproductive medicine for ensuring IVF remains both accessible and effective. Factors like delayed childbearing, lifestyle choices, and health conditions contribute to the region's fertility challenges. As many couples postpone parenthood for career or personal reasons, the appetite for fertility treatments, notably IVF, has surged.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing infertility rates
      • 3.2.1.2 Technological advancements and expansion of fertility industry
      • 3.2.1.3 Increasing median age of pregnancy
      • 3.2.1.4 Favorable government initiatives
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High costs associated with fertility procedures
      • 3.2.2.2 Social and ethical concerns especially in developing countries
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Equipment
    • 5.2.1 Microscope
    • 5.2.2 Imaging system
    • 5.2.3 Sperm analyzer system
    • 5.2.4 Ovum aspiration pump
    • 5.2.5 Micromanipulator system
    • 5.2.6 Incubator
    • 5.2.7 Gas analyzer
    • 5.2.8 Cryosystem
    • 5.2.9 Laser system
    • 5.2.10 Sperm separation system
    • 5.2.11 Cabinet
    • 5.2.12 Anti-vibration table
    • 5.2.13 Witness system
    • 5.2.14 Other equipment
  • 5.3 Reagents and media
    • 5.3.1 Embryo culture media
    • 5.3.2 Cryopreservation media
    • 5.3.3 Sperm processing media
    • 5.3.4 Ovum processing media
  • 5.4 Accessories

Chapter 6 Market Estimates and Forecast, By Type of Cycle, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Fresh non-donors
  • 6.3 Frozen non-donors
  • 6.4 Frozen donors
  • 6.5 Fresh donors

Chapter 7 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Conventional IVF
  • 7.3 IVF with intracytoplasmic sperm injections
  • 7.4 Minimal IVF
  • 7.5 IVF with donor eggs
  • 7.6 Other procedures

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Fertility clinics and IVF centers
  • 8.3 Hospitals and surgical centers
  • 8.4 Research institutes
  • 8.5 Cryobanks

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Cook Medical
  • 10.2 Esco Medical
  • 10.3 FUJIFILM Irvine Scientific, Inc.
  • 10.4 GE HealthCare Technologies, Inc.
  • 10.5 Genea BIOMEDX
  • 10.6 Gynemed GmbH and Co. KG
  • 10.7 Hamilton Thorne Ltd.
  • 10.8 IVFtech ApS
  • 10.9 Kitazato Corporation
  • 10.10 Merck KGaA
  • 10.11 Nidacon International AB
  • 10.12 The Baker Company Inc.
  • 10.13 The Cooper Companies Inc.
  • 10.14 Thermo Fisher Scientific Inc.
  • 10.15 Vitrolife Group